Your browser doesn't support javascript.
Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings.
Davies, Cristyn; Taba, Melody; Deng, Lucy; Karatas, Ceylan; Bag, Shopna; Ross, Charles; Forster, Angus; Booy, Robert; Skinner, S Rachel.
  • Davies C; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
  • Taba M; Sydney Institute of Infectious Diseases, University of Sydney, Sydney, Australia.
  • Deng L; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
  • Karatas C; Sydney Institute of Infectious Diseases, University of Sydney, Sydney, Australia.
  • Bag S; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
  • Ross C; National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Westmead, Australia.
  • Forster A; Specialty of Child and Adolescent Health, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
  • Booy R; Graduate School of Medicine, The University of Wollongong, Keiraville, Australia.
  • Skinner SR; Centre for Population Health, Western Sydney Public Health Unit, North Parramatta, Australia.
Hum Vaccin Immunother ; 18(4): 2018863, 2022 11 30.
Article in English | MEDLINE | ID: covidwho-1895717
ABSTRACT

BACKGROUND:

High-density microarray patch (HD-MAP) vaccines may increase vaccine acceptance and use. We aimed to ascertain whether professional immunizers (PIs) and other healthcare workers (HCWs) in Australia, a High-Income Country (HIC), found the HD-MAP applicator usable and acceptable for vaccine delivery.

METHODS:

This feasibility study recruited PIs and HCWs to administer/receive simulated HD-MAP administration, including via self-administration. We assessed usability against essential and desirable criteria. Participants completed a survey, rating their agreement to statements about HD-MAP administration. A subset also participated in an interview or focus group. Survey data were analyzed using descriptive statistics, and interviews were transcribed and subject to thematic analysis.

RESULTS:

We recruited 61

participants:

23 PIs and 38 HCWs. Findings indicated high usability and acceptability of HD-MAP use across both groups by a healthcare professional or trained user and for self-administration with safety measures in place. Most administrations met essential criteria, but PIs, on average, applied the HD-MAP for slightly less time than the required 10-seconds, which the HCWs achieved. PIs perceived safety concerns about home administration but found layperson self-administration acceptable in an emergency, pandemic, and rural or remote settings.

CONCLUSIONS:

Participants found HD-MAP administration usable and acceptable. Usability and acceptability are likely to be improved through end-user education and training.
Professional immunizers and healthcare workers found high-density microarray patch devices highly usable and acceptable to administer vaccines.HD-MAPs may have advantages over intramuscular injections in clinical settings and in pandemics.Vaccination with HD-MAP may improve acceptance for those with needle-related anxiety.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Vaccination Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Oceania Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2021.2018863

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Vaccination Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Oceania Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2021.2018863